These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 2022420

  • 1. Treatment of cholesterol gallstones with litholytic bile acids.
    Salen G, Tint GS, Shefer S.
    Gastroenterol Clin North Am; 1991 Mar; 20(1):171-82. PubMed ID: 2022420
    [Abstract] [Full Text] [Related]

  • 2. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
    Sahlin S.
    Eur J Surg; 1996 Jun; 162(6):463-9. PubMed ID: 8817223
    [Abstract] [Full Text] [Related]

  • 3. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF, Thistle JL.
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [Abstract] [Full Text] [Related]

  • 4. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K.
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [Abstract] [Full Text] [Related]

  • 5. Oral bile acid treatment of biliary cholesterol stones.
    Leuschner U.
    Recenti Prog Med; 1992 Nov; 83(7-8):392-9. PubMed ID: 1529153
    [Abstract] [Full Text] [Related]

  • 6. Effect of chenodeoxycholic acid and ursodeoxycholic acid administration on acyl-CoA: cholesterol acyltransferase activity in human liver.
    Abate N, Carubbi F, Bozzoli M, Bertolotti M, Farah I, Rosi A, Carulli N.
    Ital J Gastroenterol; 1994 Nov; 26(6):287-93. PubMed ID: 7949265
    [Abstract] [Full Text] [Related]

  • 7. Different effects of chenodeoxycholic acid and ursodeoxycholic acid on serum lipoprotein concentrations in patients with radiolucent gallstones.
    Leiss O, von Bergmann K.
    Scand J Gastroenterol; 1982 Aug; 17(5):587-92. PubMed ID: 7178821
    [Abstract] [Full Text] [Related]

  • 8. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
    Stiehl A, Raedsch R, Czygan P, Götz R, Männer C, Walker S, Kommerell B.
    Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
    [Abstract] [Full Text] [Related]

  • 9. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H, Roat JW, Gonzalez V, Sarva RP, Farivar S.
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [Abstract] [Full Text] [Related]

  • 10. [Prevention of recurrence after successful gallstone dissolution].
    Leiss O, von Bergmann K.
    Z Gastroenterol; 1991 Jun; 29(6):301-5. PubMed ID: 1926965
    [Abstract] [Full Text] [Related]

  • 11. Clinical perspective on the treatment of gallstones with ursodeoxycholic acid.
    Salen G.
    J Clin Gastroenterol; 1988 Jun; 10 Suppl 2():S12-7. PubMed ID: 3062079
    [Abstract] [Full Text] [Related]

  • 12. Effect of administration of ursodeoxycholic acid at bedtime on cholesterol saturation of hepatic bile in Japanese patients with gallstone.
    Inoi J, Shimizu I, Tsuji Y, Muguruma N, Shibata H, Ito S.
    J Med Invest; 1998 Aug; 45(1-4):115-22. PubMed ID: 9864972
    [Abstract] [Full Text] [Related]

  • 13. Dissolution of cholesterol gallbladder stones with bile salts.
    Leuschner U.
    Rev Invest Clin; 1990 Jul; 42 Suppl():174. PubMed ID: 19256161
    [No Abstract] [Full Text] [Related]

  • 14. Ursodeoxycholic acid for adjuvant therapy with extracorporeal shock wave lithotripsy of gallstones.
    Fromm H.
    J Clin Gastroenterol; 1988 Jul; 10 Suppl 2():S18-21. PubMed ID: 3062080
    [Abstract] [Full Text] [Related]

  • 15. Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study.
    Roda E, Bazzoli F, Labate AM, Mazzella G, Roda A, Sama C, Festi D, Aldini R, Taroni F, Barbara L.
    Hepatology; 1982 Jul; 2(6):804-10. PubMed ID: 7141392
    [Abstract] [Full Text] [Related]

  • 16. The effect of ursodeoxycholic acid on nucleation time in patients with solitary or multiple gallbladder stones.
    Tudyka J, Wechsler JG, Mason R, Maier C.
    Am J Gastroenterol; 1994 Aug; 89(8):1206-10. PubMed ID: 8053436
    [Abstract] [Full Text] [Related]

  • 17. [Changes in the pattern of serum biliary acids and lipoprotein picture during therapy with biliary acids in cholesterol lithiasis].
    Di Mario F, Angonese C, Del Favero G, Aggio L, Meggiato T, Scalon P, Basso D, Plebani M, Burlina A, Naccarato R.
    G Clin Med; 1990 Aug; 71(6-7):435-41. PubMed ID: 2258026
    [Abstract] [Full Text] [Related]

  • 18. Lack of response to chenodeoxycholic acid in obese and non-obese patients. Role of cholesterol synthesis and possible response to ursodeoxycholic acid.
    Maton PN, Murphy GM, Dowling RH.
    Gut; 1980 Dec; 21(12):1082-6. PubMed ID: 7461467
    [Abstract] [Full Text] [Related]

  • 19. The effect of chenodeoxycholic acid (CDCA) on cholesterol absorption.
    Ponz de Leon M, Carulli N, Loria P, Iori R, Zironi F.
    Gastroenterology; 1979 Aug; 77(2):223-30. PubMed ID: 447035
    [Abstract] [Full Text] [Related]

  • 20. [Per oral gallstone dissolution therapy].
    Sugata F.
    Nihon Rinsho; 1993 Jul; 51(7):1785-90. PubMed ID: 8366596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.